FDA Panel Urges Caution With Skin-Cancer-Detecting Tools

A federal advisory panel offered a bevy of suggestions about how the FDA might proceed with potential future clearances for the broad use of tools intended to analyze skin lesions for cancer risk.
Medscape Medical News